When Health Insurance Tried to Decide My Cancer Care: Appealing Cancer Insurance Denials
Appealing Cancer Insurance Denials: Fighting for PET Scans, Medicines, and the Treatment My Doctors Believed I Needed
When I was diagnosed with Stage IV uterine leiomyosarcoma, I believed my doctors and I would make the medical decisions.
I quickly learned that another voice could enter the room without ever examining me.
My health insurance company could decide that a test was unnecessary, that another test was good enough, or that a medicine did not fit neatly into its approval system.
The insurance company was not responsible for diagnosing my recurrence, treating my tumors, or explaining a missed opportunity to my family.
It could still delay or deny the care my doctors requested.
My Insurance Questioned the Need for PET Scans
At one point, my insurance company said PET scans were not needed for my cancer.
It believed a less expensive MRI should be used instead.
The problem was that an MRI and a PET scan do not always answer the same question.
An MRI can provide detailed images of a particular part of the body. A PET scan can help identify areas with increased metabolic activity throughout the areas being examined.
Which test is appropriate depends on the patient, cancer, symptoms, previous results, and what the doctor is trying to learn.
My oncologist believed the PET scan was medically appropriate for monitoring my metastatic uterine leiomyosarcoma.
The insurance company looked at its coverage rules and cost.
This Was Not a Request for a More Luxurious Test
The PET scan was not a comfort upgrade.
It was not like choosing a more expensive seat on an airplane.
My doctor was trying to monitor a rare cancer that had already spread beyond the uterus.
The imaging could help us compare areas of activity, decide whether something had changed, and determine whether additional testing or treatment was needed.
The insurer’s alternative may have been less expensive.
Less expensive did not automatically mean medically equivalent for the question my oncologist was asking.
My Doctor Had to Appeal
My cancer doctor had to help challenge the denial.
That meant explaining why the test was needed for my individual case.
The appeal could require:
* Medical records
* My cancer diagnosis and stage
* Previous imaging
* Treatment history
* Symptoms
* The purpose of the requested scan
* An explanation of why another test was not an equal substitute
* Communication between the doctor and insurer
* Additional review by the health plan
The doctor was not merely ordering a scan.
He was also defending his medical judgment to a company that had not examined me.
Patients Have Appeal Rights
When a health plan denies coverage or payment for a service, patients may have the right to ask the plan to reconsider through an internal appeal. Depending on the plan and reason for denial, an unfavorable internal decision may also qualify for review by an independent third party. The exact process, deadlines, and rights depend on the insurance arrangement and applicable rules.
Knowing an appeal is possible is important.
It does not make the process easy.
A right that requires a sick person to gather records, track deadlines, make repeated calls, and understand complicated notices can still be difficult to use.
A Denial Letter Is Only the Beginning
An insurance denial may include a reason such as:
* Not medically necessary
* Experimental or investigational
* Another test should be used first
* The service is not covered
* Prior authorization was not obtained
* The requested location is out of network
* Documentation is incomplete
* The diagnosis code does not match the request
* The plan requires a different treatment sequence
The first step is understanding exactly why the request was denied.
That sounds simple.
Denial letters can be difficult to read.
Important information may be buried in several pages of formal language.
I Needed My Doctor’s Help
There are parts of an appeal the patient can organize.
The medical reasoning often needs to come from the treating doctor.
My doctor knew:
* Why the PET scan was being requested
* What previous imaging had shown
* Why my cancer history changed the risk
* Which question the scan was intended to answer
* Why a cheaper alternative might not provide the same information
* How a delay could affect the treatment plan
A strong appeal connects the requested service to the patient’s specific medical circumstances.
It should not rely only on a general statement that the test would be helpful.
Rare Cancer Does Not Always Fit the Insurance Checklist
Insurance systems work best when a diagnosis follows a familiar path.
Uterine leiomyosarcoma is rare.
My cancer also had individual characteristics, including estrogen and progesterone receptors and an ALK fusion.
My treatment history included surgery, doxorubicin, hormone maintenance, radiation, Signatera monitoring, and eventually off-label targeted medicine.
There was not always a simple checkbox for my situation.
A coverage rule designed for a more common diagnosis might not reflect the judgment needed for my rare cancer.
Computer Systems Can Become Part of the Problem
I saw this again when lorlatinib was approved through my employer-sponsored insurance.
Lorlatinib is primarily associated with certain ALK-positive lung cancers.
My tumor also had an ALK fusion, but my diagnosis was uterine leiomyosarcoma.
The insurer’s computer system contained a fixed field connected to the more familiar cancer use.
My diagnosis did not fit neatly into it.
The system had to be adjusted so the request could be processed correctly.
A Fixed Field Can Delay a Real Patient
To a software system, the issue may look like invalid data.
To the patient, it is access to treatment.
A computer may reject the request because:
* The cancer type is unexpected
* The medicine and diagnosis are not commonly paired
* The authorization system expects a standard code
* The treatment is off label
* The manufacturer’s assistance program uses different eligibility categories
* The pharmacy and insurer are not using matching information
I work with software and understand that systems need rules.
I also understand that a fixed field should not be allowed to make a medical decision.
A rare case needs a process for human review.
Lorlatinib Cost About $23,000 for Thirty Days
The lorlatinib prescription was approximately $23,000 for a thirty-day supply.
Under my employer insurance, filling it could have brought me immediately to my approximately $8,000 annual out-of-pocket maximum.
I did not have $8,000 available to pay all at once.
Approval alone did not make the medicine accessible.
I needed help with the patient cost.
Pfizer’s Support Program Became Part of the Process
Pfizer had a program that could help with the cost.
That assistance was a blessing.
Receiving it still required the correct information and coding.
Because the medicine was being considered for uterine leiomyosarcoma rather than its more familiar lung-cancer use, the ordinary process did not work smoothly.
Pfizer eventually provided a different code so the request could be handled for my type of cancer.
I had to work with the insurer, pharmacy, manufacturer, and medical team until the pieces connected.
Vendor Support Can Determine Whether Treatment Is Possible
People may hear the phrase **patient assistance program** and imagine a simple coupon.
The process may involve:
* Eligibility rules
* Insurance information
* Income information
* Medical documentation
* Diagnosis codes
* Prescription details
* Pharmacy coordination
* Annual renewal
* Limits on which insurance plans qualify
* Communication among several organizations
I was grateful the assistance existed.
Without it, the approved medicine could still have been financially out of reach.
Then My Doctor Sent the Prescription to the VA
After radiation, I talked with my current oncologist about using lorlatinib for the ALK fusion in my tumor.
I brought my research.
I explained my reasoning.
We discussed that the combination of exemestane and lorlatinib was not a standard, proven combination for every patient with uterine leiomyosarcoma.
It was an individualized, off-label treatment decision.
My doctor sent the prescription request to the VA.
The VA Did Not Approve It Automatically
From approximately February 3 through February 10, 2025, the regional VA gynecologic oncology team worked to obtain my history from previous cancer doctors.
The regional clinician called me.
We discussed:
* My uterine leiomyosarcoma history
* Previous treatments
* Caris tumor testing
* The ALK fusion
* My research
* My doctor’s reasoning
* Why I believed targeted treatment was worth considering
* The uncertainty involved
The review was careful.
It was not a computer simply saying yes.
A knowledgeable medical professional considered my individual case.
The VA Decided the Plan Was Reasonable
After reviewing the records and speaking with me, the VA clinician agreed that the treatment approach was medically reasonable.
The VA issued the lorlatinib prescription.
It now supplies my prescriptions.
That removed a major financial barrier and added another knowledgeable person to my cancer team.
The difference was not that the VA ignored uncertainty.
It allowed a human medical review of a rare situation.
Denial and Review Are Not the Same Thing
Insurance companies and pharmacy programs do need review processes.
Not every requested test or medicine is medically appropriate for every patient.
The problem occurs when a general rule is treated as more important than the individual case.
A responsible review asks:
* What is this patient’s diagnosis?
* What has already been tried?
* What evidence supports the request?
* What are the alternatives?
* Why does the treating doctor believe this is appropriate?
* What may happen if care is delayed?
* Is specialist review needed?
* Does a rare condition require an exception?
A refusal based only on cost or an inflexible computer field is not the same as thoughtful medical review.
The Patient Becomes the Connection Between Systems
My doctors had their records.
The VA needed those records.
The insurance company needed medical justification.
The manufacturer needed the correct diagnosis and code.
The pharmacy needed an approved prescription.
The cancer center needed to know who would provide the medicine.
The patient often becomes the one person who knows where every piece is supposed to go.
That is too much responsibility for someone who is also managing cancer.
I Had to Tell the Same Story Repeatedly
Every new organization wanted an explanation.
I had to repeat:
* What cancer I had
* When it was diagnosed
* Why it was Stage IV
* Which treatments I had received
* What the tumor testing showed
* Why the doctor wanted the test or medicine
* Why the usual pathway did not fit
Repeating the story was not only administrative.
It meant repeatedly returning to the most frightening parts of my medical history.
Records Do Not Move as Easily as People Assume
One office may say it faxed the records.
The receiving organization may say nothing arrived.
A portal may show a document the reviewer cannot access.
An imaging report may arrive without the images.
The pathology report may be present while the tumor-testing report is missing.
The patient may need to call both sides.
A request can remain delayed because one page, signature, code, or report is absent.
I Learned to Keep My Own Copies
Important records may include:
* Pathology reports
* Operative reports
* Imaging reports
* Tumor-profile results
* Germline testing
* Treatment summaries
* Medication history
* Previous authorization decisions
* Denial letters
* Appeal notices
* Physician letters
* Insurance identification
* Pharmacy information
* Manufacturer-assistance paperwork
* Names and dates of telephone calls
Keeping records does not guarantee approval.
It can prevent the entire process from restarting whenever one organization says it lacks information.
Keep a Call Log
Insurance calls can blur together.
A simple log can record:
* Date
* Time
* Organization
* Telephone number
* Representative’s name or identification number
* Reference number
* What was requested
* What was promised
* Deadline
* Required documents
* Next action
CMS recommends keeping copies of appeal information and tracking communications and documents.
A call log turns a vague memory into a timeline.
Ask for the Exact Denial Reason
Do not settle for:
“It was denied.”
Ask:
* What was the formal reason?
* Which policy or coverage rule was used?
* Was it denied as not medically necessary?
* Was prior authorization missing?
* Was the code incorrect?
* Does the plan require another test first?
* Is the provider out of network?
* What documentation would change the decision?
* What is the appeal deadline?
* Where must the appeal be sent?
* Can my doctor request a peer-to-peer review?
* Does the situation qualify for urgent review?
The answer determines the next step.
A Peer-to-Peer Review May Help
In some cases, the treating doctor can speak directly with a clinician reviewing the request for the insurance company.
This may be called a peer-to-peer review.
The discussion can allow the doctor to explain the unusual medical details that did not fit into the original paperwork.
A peer-to-peer conversation does not guarantee approval.
It gives the treating professional an opportunity to defend the request medically rather than leaving the decision to codes and short form entries.
Urgent Situations May Have Faster Review Options
Some insurance processes allow an expedited or urgent appeal when waiting through the standard timeline could seriously threaten the patient’s life, health, or ability to regain maximum function. Eligibility and timing rules vary, so the denial notice and plan instructions must be reviewed carefully.
A patient should not label every appeal urgent without a medical reason.
When delay creates genuine danger, the doctor should explain that clearly.
Internal Appeal and External Review
The first challenge is often an internal appeal, asking the insurer to reconsider its own decision.
When the plan upholds certain types of denials, the patient may be eligible for an external review by an independent party that is not employed by the health plan. Medical-necessity, appropriateness, experimental-treatment, and similar disputes may qualify, depending on the plan and rules involved.
The denial notice should explain available appeal rights.
If it does not make sense, ask for help.
## Employer Plans May Have Different Paths
Employer-sponsored insurance may be fully insured or self-funded.
That distinction can affect who is ultimately responsible for the plan and which appeal rules apply.
A self-funded plan may be administered by a familiar insurance company even though the employer bears the financial risk.
CMS advises people with self-funded plans to ask the employer or plan administrator to reconsider a denial or make an exception where appropriate.
Human resources or the employee-benefits office may be able to clarify what type of plan you have.
Financial Navigators Can Help
Some cancer centers employ financial navigators or patient advocates.
They may help patients understand:
* Insurance coverage
* Out-of-pocket costs
* Prior authorization
* Assistance programs
* Payment plans
* Transportation resources
* Pharmacy options
* Appeal paperwork
NCI describes financial navigators as professionals who help patients understand costs and coverage, locate cost-saving options, and improve access to needed care.
A navigator may not overturn every denial.
The patient does not have to learn every system alone.
Doctors Need to Document the Individual Case
A medical-necessity appeal may be stronger when it clearly states:
* The exact diagnosis
* Stage and recurrence history
* Previous treatments
* Current symptoms or findings
* Relevant tumor markers or molecular results
* Why the requested service is needed
* Why covered alternatives are not equivalent
* What medical risk delay may create
* Supporting guidelines or research
* The doctor’s specific recommendation
A short statement such as “patient needs PET scan” may not explain enough.
The insurer needs the reasoning.
The patient needs the doctor to provide it.
Research Can Support the Conversation
I brought credible research and treatment guidelines to my doctor when discussing lorlatinib.
I did not write my own prescription.
I showed why I believed the ALK fusion deserved attention.
My doctor evaluated the information and made the medical request.
Research can help a patient:
* Ask better questions
* Identify a possible guideline
* Explain why a rare feature matters
* Find a specialist
* Support a second opinion
* Understand the insurer’s objection
Research should support a qualified medical argument.
It should not be presented as proof that the patient can safely choose treatment alone.
Off-Label Does Not Mean Random
An off-label use means a drug is being used in a way not specifically included in its FDA-approved labeling, such as for another cancer type.
Doctors may sometimes prescribe medicines off label when they believe the medical evidence and patient circumstances support doing so.
An insurer may require stronger justification.
In my case, the request was based on a documented ALK fusion, my treatment history, research, and discussion with oncology professionals.
It was not based on an internet rumor.
Approval Does Not Guarantee the Medicine Will Work
Lorlatinib was a reasonable individualized option.
That did not make it a guaranteed cure.
Approval meant I had access to a treatment my team and I believed was worth trying.
The medicine later caused serious side effects that required dose adjustment and additional care.
Access is the beginning of another medical decision.
It is not proof that the treatment will be effective or tolerable.
The Appeal Process Has an Emotional Cost
This article is not about scan anxiety, but insurance battles create their own emotional strain.
A denial can feel as though a company is saying:
“Your doctor’s judgment is not enough.”
It can create anger, helplessness, and fear.
It can make the patient wonder whether money is being valued more than life.
Those emotions become stronger when the cancer is rare and time matters.
The Administrative Work Takes Time From Living
Every hour spent on hold is an hour not spent resting, working, cooking, writing, or being with family.
Every appeal adds another deadline.
Every missing document requires another call.
The patient may already be using all available energy to survive treatment and maintain normal responsibilities.
Administrative work is not harmless merely because it is completed from a telephone or computer.
It consumes part of the patient’s life.
I Refused to Let the First No End the Conversation
A denial is a decision.
It is not always the final decision.
I learned to ask:
* Why was it denied?
* What information is missing?
* Who can reconsider it?
* Can my doctor speak with the reviewer?
* Is there an external review?
* Is there a manufacturer program?
* Can the VA review it?
* Is there another pharmacy?
* Is the problem medical, financial, or technical?
* Does a code need to be corrected?
Persistence did not guarantee success.
Stopping after the first no would have guaranteed that nothing changed.
I Also Had to Know When Another Option Was Acceptable
Appealing every denial is not always necessary.
Sometimes another test or medicine may truly be medically equivalent.
Sometimes the doctor may agree with the insurer’s alternative.
Sometimes a less expensive location provides the same safe service.
The question is not:
“How do I defeat the insurance company?”
The question is:
“How do my doctor and I make sure the final decision protects my health?”
The goal is appropriate care, not winning an argument.
Questions to Ask After an Insurance Denial
* What exactly was denied?
* Why was it denied?
* Was the denial medical, administrative, or coding related?
* What is the deadline to appeal?
* What documents are required?
* Can my doctor file the appeal?
* Can the doctor request peer-to-peer review?
* Is urgent review available?
* Does the plan offer an exception process?
* Can I request external review?
* Is there a patient advocate or financial navigator?
* Does the manufacturer offer assistance?
* Is another pharmacy able to process the medicine?
* Could the VA or another benefit program help?
* Is there a safe and medically equivalent alternative?
What to Keep in an Appeal Folder
* Denial notice
* Insurance policy information
* Member identification
* Medical records
* Physician letter
* Pathology
* Imaging
* Tumor testing
* Treatment history
* Guidelines or research supplied by the doctor
* Appeal form
* Fax confirmations
* Mailing receipts
* Call log
* Reference numbers
* Final decisions
* Assistance-program information
A paper folder, digital folder, or both can work.
The important part is being able to locate the information quickly.
What Loved Ones Can Do
Insurance advocacy is a practical caregiving task.
A trusted person may help by:
* Sitting on calls
* Taking notes
* Organizing documents
* Sending records
* Tracking deadlines
* Calling a financial navigator
* Checking whether forms arrived
* Helping compare pharmacy options
* Providing emotional support after a denial
The patient should decide what information the helper may access.
Written permission may be required before an insurer or medical office can discuss the case with someone else.
What I Wish Someone Had Told Me
I wish someone had told me that my doctor’s order did not guarantee insurance approval.
I wish I had known that a cheaper test could be treated as interchangeable even when my doctor believed it answered a different question.
I wish someone had explained internal appeals, external review, peer-to-peer discussions, and urgent requests before I needed them.
I wish I had known how often rare cancer would fail to fit a standard computer field.
I wish someone had told me that an approved $23,000 medicine could still be inaccessible because of an $8,000 patient responsibility.
I wish I had understood how valuable manufacturer support and VA review could become.
I wish someone had advised me to keep a call log and copies of every important record from the beginning.
Most of all, I wish someone had said:
“When insurance says no, find out what kind of no it is. Some denials can be challenged, corrected, reviewed, or solved through another path.”
Hope for Today
My insurance company questioned PET scans because it believed cheaper imaging should be used.
My oncologist appealed.
My lorlatinib request did not fit the computer system because the medicine was associated with a different cancer.
The system had to be changed.
The medicine cost approximately $23,000 for thirty days.
The annual patient cost under my employer insurance could have reached approximately $8,000 immediately.
I worked with the insurer, pharmacy, manufacturer, doctor, and eventually the VA.
The regional VA gynecologic oncology clinician reviewed my history, tumor testing, research, and medical reasoning.
She agreed the plan was reasonable.
The VA provided the medicine.
None of those steps guaranteed the outcome.
They gave me access to the care my team and I had decided was worth trying.
Insurance companies have rules.
Computer systems have fields.
Pharmacies have procedures.
Manufacturers have programs.
The VA has review requirements.
The patient has one life.
I learned not to assume that the first denial was the end.
I asked why.
I gathered records.
I involved my doctors.
I kept calling.
I used manufacturer support.
I found another pathway.
I did not do this because I enjoyed fighting systems.
I did it because medical access can determine which choices a cancer patient is able to make.
Frequently Asked Questions
Can a patient appeal an insurance denial?
Many patients have the right to request internal reconsideration of a denial. Some cases may also qualify for independent external review. The process depends on the plan and reason for denial.
What should I read first in a denial notice?
Find the exact denial reason, appeal deadline, required documents, and instructions for requesting reconsideration.
Can a doctor help with the appeal?
Yes. The treating doctor may provide medical-necessity documentation, submit an appeal, or request a peer-to-peer discussion.
What is an expedited appeal?
It is a faster review that may be available when waiting through the standard process could seriously threaten health, life, or recovery. Eligibility varies.
What is external review?
External review is reconsideration by an independent third party after certain health-plan denials.
Why did my insurance question PET scans?
The insurer believed less expensive MRI testing should be used. My oncologist believed PET imaging was appropriate for my individual cancer-monitoring needs and helped appeal.
Why was lorlatinib difficult to process?
My cancer had an ALK fusion, but my diagnosis was uterine leiomyosarcoma rather than the cancer type more commonly associated with the medicine. The coding and computer process did not fit the rare use easily.
Did the VA approve lorlatinib automatically?
No. A regional gynecologic oncology clinician gathered records, discussed my testing and reasoning with me, and determined that the individualized approach was medically reasonable.
What is a financial navigator?
A financial navigator helps patients understand costs, insurance coverage, assistance programs, and other financial aspects of medical care.
Does winning an appeal mean a treatment will work?
No. Approval provides access. Effectiveness and side effects must still be monitored by the medical team.
Support on Your Journey
An insurance denial can make a patient feel powerless at the moment she most needs access to care.
Surviving Life Lessons Community Groups are being formed so patients, survivors, and caregivers can discuss insurance denials, appeals, prior authorization, prescription assistance, VA coordination, rare-cancer exceptions, and medical-record organization.
Neighbor Chat offers a quieter one-on-one place to talk when another denial or administrative barrier feels like one problem too many.
Next Step Coaching can help organize denial notices, questions, call logs, records, and the next person to contact. It does not replace legal advice, insurance professionals, medical judgment, financial navigation, employer-benefits assistance, or VA-accredited representation.
The first no may not be the final answer.
Your Story Matters
We need your nice comments below! Your thoughts, experiences, and lessons learned might be exactly what someone else needs to hear today.
Drop a comment, Say Hello, and join the conversation.
Find Your Community
No one should have to face life's challenges alone. At Surviving Life Lessons, we believe in life survivors helping life strugglers. Explore our growing Community Groups to connect with others who understand your journey, share encouragement, and find hope through meaningful conversations. You'll also have the opportunity to introduce yourself and share your own story of overcoming. Your story matters. It may be the encouragement someone else needs to keep moving forward, reminding them that they are not alone and that hope is always possible.
Need More Personalized Support?
Everyone's journey is unique. If you're looking for personalized guidance, encouragement, or one-on-one support, explore our services to find the option that's right for you. We're here to help you take your next step with confidence and hope.
Helpful Resources for Your Journey
Explore our collection of books, journals, coloring books, and printable PDFs designed to encourage, inspire, and support you every step of the way.
References
Centers for Medicare & Medicaid Services. “Appealing Denials.” www.cms.gov/medicare/appeals-and-grievances/appealing-denials
Centers for Medicare & Medicaid Services. “Action Plan: Health Insurance Plan Denied a Claim.” www.cms.gov/cciio/resources/files/appeals-action-plan
HealthCare.gov. “Appealing an Insurance Company Decision.” www.healthcare.gov/appeal-insurance-company-decision
HealthCare.gov. “External Review.” www.healthcare.gov/appeal-external-review
HealthCare.gov. “Getting a Faster Appeal.” www.healthcare.gov/appeal-fast-track
National Cancer Institute. “Financial Navigators Reduce the Cost of Cancer Care.” www.cancer.gov/news-events/cancer-currents-blog/2020/financial-navigators-cancer-care-costs
National Cancer Institute Dictionary of Cancer Terms. “Financial Navigator.” www.cancer.gov/publications/dictionaries/cancer-terms/def/financial-navigator
---
**Disclaimer:** This article shares my personal experience and general educational information. It is not medical, legal, insurance, financial, employment-benefits, pharmaceutical, or VA-claims advice. Appeal rights, deadlines, assistance programs, plan structures, and coverage vary. Review the denial notice and seek help from the insurer, treating doctor, employer-benefits office, patient advocate, financial navigator, state insurance department, qualified attorney, or accredited VA representative when appropriate.
About the Author:
.png){kind=small}
Comments